Literature DB >> 7637807

Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes.

L Venance1, D Piomelli, J Glowinski, C Giaume.   

Abstract

Anandamide, an endogenous arachidonic acid derivative that is released from neurons and activates cannabinoid receptors, may act as a transcellular cannabimimetic messenger in the central nervous system. The biological actions of anandamide and the identity of its target cells are, however, still poorly documented. Here we show that anandamide is a potent inhibitor of gap-junction conductance and dye permeability in striatal astrocytes. This inhibitory effect is specific for anandamide as compared to co-released congeners or structural analogues, is sensitive to pertussis toxin and to protein-alkylating agents, and is neither mimicked by cannabinoid-receptor agonists nor prevented by a cannabinoid-receptor antagonist. Glutamate released from neurons evokes calcium waves in astrocytes that propagate via gap junctions, and may, in turn, activate neurons distant from their initiation sites in astrocytes. We find that anandamide blocks the propagation of astrocyte calcium waves generated by either mechanical stimulation or local glutamate application. Thus, by regulating gap-junction permeability, anandamide may control intercellular communication in astrocytes and therefore neuron-glial interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637807     DOI: 10.1038/376590a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  77 in total

1.  Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

Authors:  J J Rodriguez; K Mackie; V M Pickel
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

2.  Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.

Authors:  A Ameri; A Wilhelm; T Simmet
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 3.  Components of astrocytic intercellular calcium signaling.

Authors:  E Scemes
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

Review 4.  Two independent forms of activity-dependent potentiation regulate electrical transmission at mixed synapses on the Mauthner cell.

Authors:  Roger Cachope; Alberto E Pereda
Journal:  Brain Res       Date:  2012-07-04       Impact factor: 3.252

5.  A novel role for FGF and extracellular signal-regulated kinase in gap junction-mediated intercellular communication in the lens.

Authors:  A C Le; L S Musil
Journal:  J Cell Biol       Date:  2001-07-09       Impact factor: 10.539

6.  N-Acylethanolamines in signal transduction of elicitor perception. Attenuation Of alkalinization response and activation of defense gene expression

Authors: 
Journal:  Plant Physiol       Date:  1999-12       Impact factor: 8.340

Review 7.  [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders].

Authors:  U Schneider; J Seifert; M Karst; J Schlimme; K Cimander; K R Müller-Vahl
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

8.  Sympathetic sprouting near sensory neurons after nerve injury occurs preferentially on spontaneously active cells and is reduced by early nerve block.

Authors:  Wenrui Xie; Judith Ann Strong; Huiqing Li; Jun-Ming Zhang
Journal:  J Neurophysiol       Date:  2006-10-25       Impact factor: 2.714

9.  Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

Authors:  H Cadas; S Gaillet; M Beltramo; L Venance; D Piomelli
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

Review 10.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.